Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Proc Natl Acad Sci U S A ; 98(25): 14280-5, 2001 Dec 04.
Article in English | MEDLINE | ID: mdl-11724923

ABSTRACT

beta-Lactamases are the resistance enzymes for beta-lactam antibiotics, of which four classes are known. beta-lactamases hydrolyze the beta-lactam moieties of these antibiotics, rendering them inactive. It is shown herein that the class D OXA-10 beta-lactamase depends critically on an unusual carbamylated lysine as the basic residue for both the enzyme acylation and deacylation steps of catalysis. The formation of carbamylated lysine is reversible. Evidence is presented that this enzyme is dimeric and carbamylated in living bacteria. High-resolution x-ray structures for the native enzyme were determined at pH values of 6.0, 6.5, 7.5, and 8.5. Two dimers are present per asymmetric unit. One monomer in each dimer was carbamylated at pH 6.0, whereas all four monomers were fully carbamylated at pH 8.5. At the intermediate pH values, one monomer of each dimer was carbamylated, and the other showed a mixture of carbamylated and non-carbamylated lysines. It would appear that, as the pH increased for the sample, additional lysines were "titrated" by carbamylation. A handful of carbamylated lysines are known from protein crystallographic data, all of which have been attributed roles in structural stabilization (mostly as metal ligands) of the proteins. This paper reports a previously unrecognized role for a noncoordinated carbamylate lysine as a basic residue involved in mechanistic reactions of an enzyme, which indicates another means for expansion of the catalytic capabilities of the amino acids in nature beyond the 20 common amino acids in development of biological catalysts.


Subject(s)
beta-Lactamases/chemistry , Acylation , Catalytic Domain , Crystallography, X-Ray , Dimerization , Hydrogen-Ion Concentration , Kinetics , Lysine/chemistry , Magnetic Resonance Spectroscopy , Models, Molecular , Mutagenesis, Site-Directed , Protein Structure, Quaternary , Pseudomonas/enzymology , Pseudomonas/genetics , beta-Lactamases/classification , beta-Lactamases/genetics , beta-Lactamases/metabolism
2.
Bioorg Chem ; 29(3): 140-5, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11437389

ABSTRACT

beta-Lactamases of classes A and C are the two most prevalent resistant determinants to beta-lactam antibiotics among bacterial pathogens. Both these enzymes pursue different mechanisms for their catalytic processes, highlighted by the fact that the hydrolytic water molecule in each approaches the ester of the intermediary acyl-enzyme species from the opposite ends. 6,6-Bis(hydroxylmethyl)penicillanate was designed as an inhibitor that would impair the approach of the hydrolytic water molecule in either of these enzymes upon formation of the acyl-enzyme species. The design, synthesis, and kinetic evaluation of this inhibitor are disclosed herein.


Subject(s)
Enzyme Inhibitors/pharmacology , Penicillanic Acid/chemical synthesis , Penicillanic Acid/pharmacology , beta-Lactamase Inhibitors , Enterobacter cloacae/enzymology , Enzyme Inhibitors/chemical synthesis , Escherichia coli/enzymology , Kinetics , Magnetic Resonance Spectroscopy , Penicillanic Acid/analogs & derivatives
3.
Structure ; 8(12): 1289-98, 2000 Dec 15.
Article in English | MEDLINE | ID: mdl-11188693

ABSTRACT

BACKGROUND: beta-lactam antibiotic therapies are commonly challenged by the hydrolytic activities of beta-lactamases in bacteria. These enzymes have been grouped into four classes: A, B, C, and D. Class B beta-lactamases are zinc dependent, and enzymes of classes A, C, and D are transiently acylated on a serine residue in the course of the turnover chemistry. While class A and C beta-lactamases have been extensively characterized by biochemical and structural methods, class D enzymes remain the least studied despite their increasing importance in the clinic. RESULTS: The crystal structure of the OXA10 class D beta-lactamase has been solved to 1.66 A resolution from a gold derivative and MAD phasing. This structure reveals that beta-lactamases from classes D and A, despite very poor sequence similarity, share a similar overall fold. An additional beta strand in OXA10 mediates the association into dimers characterized by analytical ultracentrifugation. Major differences are found when comparing the molecular details of the active site of this class D enzyme to the corresponding regions in class A and C beta-lactamases. In the native structure of the OXA10 enzyme solved to 1.8 A, Lys-70 is carbamylated. CONCLUSIONS: Several features were revealed by this study: the dimeric structure of the OXA10 beta-lactamase, an extension of the substrate binding site which suggests that class D enzymes may bind other substrates beside beta-lactams, and carbamylation of the active site Lys-70 residue. The CO2-dependent activity of the OXA10 enzyme and the kinetic properties of the natural OXA17 mutant protein suggest possible relationships between carbamylation, inhibition of the enzyme by anions, and biphasic behavior of the enzyme.


Subject(s)
Bacterial Proteins , Hexosyltransferases , Peptidyl Transferases , Pseudomonas aeruginosa/enzymology , beta-Lactamases/chemistry , Amino Acid Sequence , Binding Sites , Carrier Proteins/antagonists & inhibitors , Catalysis , Crystallization , Crystallography, X-Ray , Dimerization , Evolution, Molecular , Molecular Sequence Data , Muramoylpentapeptide Carboxypeptidase/antagonists & inhibitors , Penicillin-Binding Proteins , Penicillins/metabolism , Protein Structure, Secondary , Protein Structure, Tertiary , Pseudomonas aeruginosa/drug effects , Sequence Alignment , Sequence Homology, Amino Acid , beta-Lactam Resistance , beta-Lactamases/metabolism , beta-Lactamases/pharmacology
4.
J Antibiot (Tokyo) ; 53(10): 1022-7, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11132946

ABSTRACT

6-(Hydroxyalkyl)penicillanates have proven helpful as probes for the mechanisms of beta-lactamases, enzymes of resistance for beta-lactam antibiotics. The present report summarizes the concepts on design, syntheses and use of these molecules in mechanistic studies of beta-lactamases.


Subject(s)
Molecular Probes , Penicillanic Acid/analogs & derivatives , beta-Lactamases/metabolism , Drug Design , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Penicillanic Acid/chemistry , Penicillanic Acid/metabolism , Penicillanic Acid/pharmacology , Substrate Specificity , beta-Lactamase Inhibitors , beta-Lactamases/chemistry
5.
Biochemistry ; 38(30): 9570-6, 1999 Jul 27.
Article in English | MEDLINE | ID: mdl-10423234

ABSTRACT

The clinical use of beta-lactam antibiotics combined with beta-lactamase inactivators, such as clavulanate, has resulted in selection of beta-lactamases that are insensitive to inactivation by these molecules. Therefore, therapeutic combinations of an enzyme inactivator and a penicillin are harmless for bacteria harboring such an enzyme. The TEM beta-lactamase variants are the most frequently encountered enzymes of this type, and presently, 20 variants are designated as inhibitor-resistant TEM ("IRT") enzymes. Three mutations appear to account for the phenotype of the majority of IRT enzymes, one of them being the Asn276Asp substitution. In this study, we have characterized the kinetic properties of the inhibition process of the wild-type TEM-1 beta-lactamase and of its Asn276Asp variant with the three clinically used inactivators, clavulanic acid (clavulanate), sulbactam, and tazobactam, and we report the X-ray structure for the mutant variant at 2.3 A resolution. The changes in kinetic parameters for the interactions of the inhibitors with the wild-type and the mutant enzymes were more pronounced for clavulanate, and relatively inconsequential for sulbactam and tazobactam. The structure of the Asn276Asp mutant enzyme revealed a significant movement of Asp276 and the formation of a salt bridge of its side chain with the guanidinium group of Arg244, the counterion of the inhibitor carboxylate. A water molecule critical for the inactivation chemistry by clavulanate, which is observed in the wild-type enzyme structure, is not present in the crystal structure of the mutant variant. Such structural changes favor the turnover process over the inactivation chemistry for clavulanate, with profound phenotypic consequences. The report herein represents the best studied example of inhibitor-resistant beta-lactamases.


Subject(s)
Clavulanic Acid/pharmacology , Enzyme Inhibitors/pharmacology , Escherichia coli/enzymology , beta-Lactamase Inhibitors , beta-Lactamases/chemistry , Asparagine/chemistry , Asparagine/genetics , Aspartic Acid/chemistry , Aspartic Acid/genetics , Crystallography, X-Ray , Enzyme Activation/drug effects , Enzyme Activation/genetics , Escherichia coli/drug effects , Kinetics , Models, Molecular , Mutagenesis, Site-Directed , Recombinant Proteins/antagonists & inhibitors , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Static Electricity , beta-Lactam Resistance , beta-Lactamases/genetics , beta-Lactamases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...